Related Experiment Video
Updated: Feb 22, 2026

07:55
Simultaneous Calcium Imaging and Glucose Stimulation in Living Zebrafish to Investigate In Vivo β-Cell Function
Published on: September 21, 2021
2.1K
Visualization of biodistribution of Zn complex with antidiabetic activity using semiconductor Compton camera GREI
Masayuki Munekane1,2, Shinji Motomura3, Shinichiro Kamino1,3
1Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama University, 1-1-1 Tsushimanaka, Kita-ku, Okayama 700-8530, Japan.
Biochemistry and Biophysics Reports
|September 29, 2017
Summary
This study introduces Gamma-ray Emission Imaging (GREI) to track antidiabetic zinc (Zn) complexes in vivo. The imaging revealed that Zn accumulation in the heart correlates with the potent antidiabetic activity of the [Zn(opt)2] complex.
Area of Science:
- Biomedical imaging
- Nuclear medicine
- Pharmacology
Background:
- Zinc complexes show promise as antidiabetic agents, but their pharmacological mechanisms remain unclear due to a lack of biodistribution studies.
- Noninvasive imaging techniques are crucial for understanding drug candidate distribution in living organisms.
Purpose of the Study:
- To apply Gamma-ray Emission Imaging (GREI) for noninvasive biodistribution analysis of antidiabetic zinc complexes.
- To investigate the relationship between zinc complex distribution and antidiabetic activity.
Main Methods:
- Produced 65Zn via the natCu(p,n) reaction for GREI experiments.
- Administered 65Zn-labeled di(1-oxy-2-pyridinethiolato)zinc [Zn(opt)2], ZnCl2, and di(l-histidinato)zinc intravenously.
- Visualized biodistribution using GREI and validated with invasive assays.
Main Results:
- GREI successfully visualized the biodistribution of 65Zn-labeled zinc complexes in vivo.
- Accumulation of 65Zn was observed in the cardiac blood pool for the potent antidiabetic agent [Zn(opt)2].
- GREI proved effective for biodistribution analysis of antidiabetic zinc complexes.
Conclusions:
- GREI is a powerful tool for studying the biodistribution of antidiabetic zinc complexes.
- Slow zinc elimination from the blood may be linked to the antidiabetic efficacy of [Zn(opt)2].
- This study provides new insights into the pharmacokinetics of antidiabetic zinc complexes.

